Showing results (91-100 of 1,370) with videos related to
Sort By:
Pageof 137
Drug Development Research|August 8, 2019
Montelukast modifies simvastatin-induced myopathy and hepatotoxicityMohammad S Hareedy, Esraa A Ahmed, Marwa F AliDrug Development Research|August 10, 2019
Design, synthesis, and biological activity evaluation of BACE1 inhibitors with antioxidant activityHe-Min Li, Shao-Peng Yu, Tian-Yuan Fan, et al.Drug Development Research|September 16, 2022
Synthesis and evaluation of [177 Lu]Lu-labeled porphyrin loaded PAMAM dendrimer: Impact on tumor uptake and pharmacokineticsNaveen Kumar, Mohini Guleria, Avik Chakraborty, et al.Drug Development Research|February 13, 2021
Insights into antimicrobial peptides in fighting anthrax: A reviewTheodore Ebenezer Leonard, Elsabda Siratan, Leonny Yulita Hartiadi, et al.Drug Development Research|February 15, 2021
Interferon beta 1a (Rebif®) in relapsing remitting multiple sclerosisReinier Cardentey Sánchez, Amado Díaz de la Fe, Alejandro Peláez Suarez, et al.Drug Development Research|March 5, 2021
Synthesis of benzimidazole based hydrazones as non-sugar based α-glucosidase inhibitors: Structure activity relation and molecular dockingMuhammad Umair Ahmad, Muhammad Rafiq, Bakhtawar Zahra, et al.Drug Development Research|August 29, 2025
Sestrin2 Regulates Mitochondrial Function and Autophagy via Nrf2/SIRT3 Signaling to Ameliorate Hypoxia/Reoxygenation-Induced Rat's Cardiomyocyte InjuryTong Liu, Jiajie Kong, Zhaobin Li, et al.Drug Development Research|September 5, 2025
Effects of a Dendritic Cell Vaccine Loaded With Whole Tumor Antigen on Bladder Cancer Model in hu-PBL-SCID MiceBin Wang, Kai Wu, Yu Cui, et al.Drug Development Research|September 5, 2025
Exploring the Topoisomerase II Inhibitory Potential of Steroidal Drugs as a Recommended Mechanism of Action for Their Anticancer Activity: In Silico and In Vitro AssessmentsAhmed A Al-Karmalawy, Mohamed E Eissa, Ayman Abo Elmaaty, et al.Drug Development Research|August 19, 2021
Ketotifen is a Prodrug. Norketotifen is the active metaboliteAxel Karl Gunnar Aberg, Nada Arulnesan, Gordon T Bolger, et al.Pageof 137